XOLAIR
Live / Registered — Registered and renewed (as of 12 Jan 2026)
What this means for you
Registered since 25 Apr 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Apr 2026).
Record
- Serial number
- 78296612
- Registration number
- 3086141
- Mark type
- Word mark
- Filed
- 05 Sept 2003
- Published for opposition
- 11 May 2004
- Registered
- 25 Apr 2006
- Next maintenance due
- 25 Apr 2026
- Attorney of record
- MAURY M. TEPPER III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of IgE-mediated disorders
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, Basel, CH
Prior registrations
Prosecution history
- 12 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Jan 2026 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 12 Jan 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Oct 2025 — TEAS SECTION 8 & 9 RECEIVED
- 25 Apr 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 30 Mar 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 30 Mar 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Mar 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Jan 2016 — TEAS SECTION 8 & 9 RECEIVED
- 25 Apr 2015 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Sept 2011 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Sept 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Sept 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL